Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0026936 (Mycoplasma)
 14,761 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Arginine deiminase (EC 3.5.3.6) from Mycoplasma arthritidis ATCC 14152 has been purified 6-fold by a new procedure, protamine sulfate fractionation and DEAE-agarose chromatography. The yield was 75 to 85%. The homogeneity of the final preparation was demonstrated by gel filtration, sodium dodecyl sulfate-gel electrophoresis, NH2-terminal analysis, and polyacrylamide gel electrophoresis at two pH values. The enzyme has a molecular weight of 80,000 as measured by gel filtration. The dimeric nature of the enzyme is suggested by the molecular weight of 49,000 from sodium dodecyl sulfate-gel electrophoresis. Isoelectric focusing in polyacrylamide gels showed a major band corresponding to an isoelectric point of 7.0 and sometimes minor bands having lower isoelectric points. The ultraviolet spectrum exhibits a maximum at 278 nm. The enzyme has high affinity for L-arginine, with a Km value of 4 +/- 1 micronM at pH 7.2, 25 degrees. Mycoplasma arthritidis produces two distinct forms of arginine deiminase. Deiminase I is isolated from cells harvested during logarithmic phase; deiminase II is obtained from late logarithmic or early stationary phase cells. The two forms are resolved by DEAE-agarose chromatography and by polyacrylamide gel electrophoresis. Deiminase II elutes later from a DEAE-agarose column and moves toward the anode faster than deiminase I at pH 9.5 The two forms also have different specific activities and 280:260 spectral ratios. Each form has the same Km and molecular weight. A third form of the enzyme, deiminase III, can be generated by incubating deiminase II at pH 9.8, or in 50% saturated ammonium sulfate, pH 7.0, at 25 degrees. The transformation can be followed by chromatography and is completed within 10 h. The specific activity of deiminase III is 1.3 times that of deiminase II. No change in molecular weight or subunit dissociation was observed during the transformation. Deiminiase III has the same specific activity, absorbance ratio A280:A260, and electrophoretic properties as deiminase I. Deiminase I undergoes no change upon incubation at pH 9.8 for several days.
 ...
PMID:Arginine deiminase from Mycoplasma arthritidis. Evidence for multiple forms. 85 96

A suitable procedure for the production of human monokines was defined as 'differentiation-induction' culture. Human monocytic leukemia THP-1 cells were well-differentiated from nonfunctional promonocytes into macrophage-like cells by the induction with a combination of mezerein, retinoic acid, and a Mycoplasma fermentans extract. The differentiated THP-1 cells secreted a high amount of macrophage differentiation-inducing factor (DIF) activity and concomitantly produced other known monokines, such as tumor necrosis factor-alpha (TNF-alpha), interleukin-1 alpha (IL-1 alpha) and interleukin-1 beta (IL-1 beta), into the medium. These results suggest that other novel human monokines may also be found in the conditioned medium of THP-1 cells induced by the 'differentiation-induction' culture conditions defined in this study. Macrophage DIF was purified to homogeneity and NH2-terminal amino acid sequence analysis revealed that macrophage DIF is very similar or identical to human leukemia inhibitory factor (LIF). The cDNA encoding human LIF was isolated using the polymerase chain reaction, and a clone producing 3.7 micrograms/10(6) cells day recombinant LIF was selected from Chinese hamster ovary (CHO) cells which were transfected with the LIF cDNA. The recombinant LIF production in CHO cells was quantified using MTT reduction assay with M1 cells.
 ...
PMID:"Differentiation induction" culture of human leukemic myeloid cells stimulates high production of macrophage differentiation inducing factor. 136 27

The identification of specific T cell and B cell epitopes of the P1 protein, which functions as an adhesin and as a major antigen of Mycoplasma pneumoniae, has become of central interest for the design of synthetic vaccines. Here we report the isolation from guinea pigs infected intranasally with M. pneumoniae of hilar and bronchial T lymphocytes which proliferated after in vitro stimulation with sonicated M. pneumoniae whole-cell antigen and with the isolated P1 protein. For more detailed information on T cell epitopes, a 51-amino-acid region (histidine 821 to glycine 871; numbered from the NH2-terminal end) of the P1 protein was analyzed for a T cell epitope. An octapeptide, S-G-S-R-S-F-L-P (starting at amino acid 845), stimulated in vitro lymphocytes of bronchial washings and of hilar lymph nodes. Furthermore, this T cell-stimulating amino acid sequence was located at the C-terminal end of a B cell epitope with the sequence T-N-T (starting at amino acid 842).
 ...
PMID:A B cell-, T cell-linked epitope located on the adhesin of Mycoplasma pneumoniae. 169 2

Overlapping octapeptides from the amino acid sequence of the adherence protein of Mycoplasma pneumoniae were synthesized and used as the antigen in an enzyme-linked immunosorbent assay with serum samples from M. pneumoniae-infected patients. Of a sequence of 338 amino acids positioned between leucine 801 and leucine 1139, only two regions with immunodominant continuous epitopes were detected. The immunoglobulin G and immunoglobulin M antibodies of child and adult patients reacted especially with the NH2-(810)-W-I-G-N-G-Y-R-Y peptide but also reacted with the NH2-(1124)-F-T-D-F-V-K-P-R peptide.
 ...
PMID:Immunodominant epitopes of the adhesin of Mycoplasma pneumoniae. 169 81

These experiments were done to learn whether Mycoplasma pulmonis infections of the respiratory tract of rats can potentiate "neurogenic inflammation" and whether this potentiation is amplified by factors that exacerbate the infections. Pathogen-free F344 rats were inoculated intranasally with M. pulmonis or with sterile culture medium and then lived for 4 wk in an ammonia-free atmosphere or in air containing ammonia (100 parts per million). Neurogenic inflammation was evoked by an intravenous injection of capsaicin, and 5 min later the magnitude of the response was quantified by measuring the amount of extravasation of two tracers, Monastral blue pigment and Evans blue dye. We found that vascular permeability in the tracheas of all rats was normal in the absence of capsaicin. However, a 75-micrograms/kg dose of capsaicin, which caused almost no extravasation of Evans blue in the tracheas of pathogen-free controls (17 +/- 3 ng/mg; mean +/- SE), produced extensive extravasation in the infected rats (135 +/- 18 ng/mg; P less than 0.001). Similarly, this dose of capsaicin produced 30 times as much Monastral blue extravasation in the infected rats (area density = 47 +/- 8% of surface area) as it did in the pathogen-free rats (1.6 +/- 0.5%; P less than 0.001), a difference that resulted from increases in the number of Monastral blue-labeled postcapillary venules and in the amount of labeling per venule. Exposure of the infected rats to ammonia exacerbated the infections, further increased the number of Monastral blue-labeled vessels and the amount of labeling per vessel, and made the rats so sensitive to capsaicin that a normally tolerable dose of 150 micrograms/kg i.v. caused fatal apnea. Ammonia did not have these effects in pathogen-free rats. We conclude that M. pulmonis infections of the airway mucosa cause a potent, long-lasting potentiation of neurogenic inflammation, which results in part from an increase in the number and responsiveness of mediator-sensitive postcapillary venules. These changes can be amplified by environmental factors such as ammonia which exacerbate the infections.
 ...
PMID:Mycoplasma pulmonis infections cause long-lasting potentiation of neurogenic inflammation in the respiratory tract of the rat. 199 95

To evaluate lesions of ammonia exposure and Mycoplasma pulmonis infection in gnotobiotic F344/N rats, groups of rats were inoculated with M. pulmonis, exposed to 76 micrograms/liter (100 parts per million) ammonia, or both, or served as controls. Six rats from each group were killed 3, 5, 7, and 9 days after inoculation and their respiratory organs prepared for histologic examination. Lesions were assessed by subjective scoring and computerized morphometry, and results obtained by the two methods were compared to assess agreement of results. Lesions were limited to the nasal passages. Ammonia exposure resulted in hyperplastic and degenerative changes in the anterior nasal epithelium. Lesions of mycoplasmosis were more severe in ammonia-exposed than unexposed rats, but qualitative differences in lesions were not apparent. Results of the two methods agreed in assessment of submucosal inflammatory cell accumulation. Epithelial lesions were difficult to evaluate by both methods in infected, ammonia-exposed rats. In evaluation of lesions of ammonia exposure alone, agreement was adequate. Both methods indicated that exudates were significantly greater in ammonia-exposed infected rats than in non-exposed infected rats. Thus, scoring and morphometry provided similar assessments of differences in lesion severity among the treatment groups.
 ...
PMID:Evaluation by scoring and computerized morphometry of lesions of early Mycoplasma pulmonis infection and ammonia exposure in F344/N rats. 377 12

The longitudinal Mycoplasma pulmonis-host relationships in rats 1 to 72 weeks of age were investigated in a conventional breeding colony of Sprague-Dawley rats with enzootic murine respiratory mycoplasmosis (MRM). Mean intracage ammonia (NH3) concentrations of 52 +/- 21 micrograms/1 and active Sendai virus infections during the first month of life were associated with important early events in MRM. There was rapid colonization of proximal airways by large numbers of M. pulmonis in most rats by 2 weeks of age and the lungs by 6 weeks. The prevalence of lesions of MRM peaked by 3 weeks in nasal passages, later in middle ears, larynx and trachea, and not until 8 weeks in lungs. Approximately 10% of rats 8 weeks of age and older had bronchiectasis and/or bronchiolectasis, usually restricted to a few airways. Despite continued high NH3 concentrations (42 +/- 14 micrograms/1 in cages of weanlings and 86 +/- 45 micrograms/1 in cages of adults), M. pulmonis populations declined dramatically by 8 weeks of age. Nevertheless, in older rats lesions continued to be extremely prevalent in proximal airways. Mycoplasma pulmonis infection and disease persisted in respiratory tracts of most rats through 72 weeks of age, despite high serum concentrations of mycoplasma-specific IgM and IgG antibodies. These interrelationships of M. pulmonis, host, and environment may be representative of many breeding colonies of rats that have enzootic MRM.
 ...
PMID:Mycoplasma pulmonis-host relationships in a breeding colony of Sprague-Dawley rats with enzootic murine respiratory mycoplasmosis. 391 11

Ammonia (NH3) from soiled cage bedding is known to enhance the progression and severity of murine respiratory mycoplasmosis in rats. To test the hypothesis that NH3 directly or indirectly enhances the growth of Mycoplasma pulmonis in vivo, pathogen-free F344 rats were inoculated intranasally with 1 x 10(4) to 4 x 10(4) or 4 x 10(6) to 5 x 10(6) colony-forming units of M. pulmonis and exposed to less than or equal to 1.5 or 76 microgram of NH3 per liter (less than or equal to 2 or 100 ppm, respectively). Nasal passages, larynges, tracheas, and lungs from rats killed at intervals up to 28 days after inoculation were quantitatively cultured. Growth of M. pulmonis was much greater in NH3-exposed rats than in controls, particularly in those inoculated with the lower dose. Increases in M. pulmonis populations were more rapid in proximal airways than in distal airways. Serum immunoglobulin G and M antibody responses to M. pulmonis as measured by an enzyme-linked immunosorbent assay were greater in NH3-exposed rats. In other experiments, the nasal passages absorbed virtually all NH3 when the rats were exposed to less than 380 micrograms of NH3 per liter (500 ppm), indicating that NH3 induced increases in the numbers of organisms in the distal respiratory tract, probably by a secondary, rather than a direct, effect. Also, NH3 exposure did not inhibit pulmonary antibacterial activity as measured by clearance of radiolabeled Staphylococcus epidermidis. The growth of M. pulmonis in vitro was inhibited by 1 mM NH4+ added to the medium as NH4OH but not by NH4+ concentrations of 0.5, 0.1, or 0.01 mM, suggesting that NH3 increases growth indirectly through effects on the host.
 ...
PMID:Intracage ammonia promotes growth of Mycoplasma pulmonis in the respiratory tract of rats. 714 91

Murine respiratory mycoplasmosis (formerly murine chronic respiratory disease) has been conclusively shown to be due to Mycoplasma pulmonis. Based upon experimental studies, it is clear that the disease is an insidious, protracted process involving a variety of interrelated factors. Intracage NH3 (25 to 250 ppm) greatly increases disease incidence, severity and progression. In mice, the presence of other infectious agents, like Sendai virus, also potentiates disease. However, comparisons of animals matched for age, sex, microbial, and environmental factors indicate that heredity is one of the most critical determinants of disease. M. pulmonis is generally thought to be transmitted via aerosol, but recent evidence indicates that in utero transmission is also possible. M. pulmonis can colonize and produce disease in all parts of the female genital tract. While the natural occurrence of both respiratory and genital mycoplasmoses seriously restricts the usefulness of rats and mice for other research purposes, the experimental diseases represent useful models for the study of human disease, particularly mechanisms involved in chronic pulmonary inflammation and reproductive failure.
 ...
PMID:Respiratory and genital mycoplasmosis of laboratory rodents: implications for biomedical research. 728 96

The arginine deiminase (AD) gene was cloned from Mycoplasma arginini and expressed in the cytosol of Escherichia coli as inclusion bodies with an expression level of at least 20% of the total bacterial proteins. The inclusion bodies were solubilized with 6 M guanidine hydrochloride (Gdn-HCl) under reducing conditions, in order to avoid incorrect disulfide-bond formation of the recombinant (r-) AD molecules, and renaturation was performed under various refolding conditions. The optimum renaturation conditions were found to be incubation for 90 h at pH 7.5 and 15 degrees C. The resulting completely refolded r-AD was purified to homogeneity by anion-exchange and arginine-affinity chromatography and its activity yield was 72.5%. The specific activity of the purified r-AD was comparable to and its amino acid composition was identical to those of Mycoplasma AD, and NH2-terminal sequence analysis revealed that its methionine residue corresponding to the translation initiation codon had been removed completely. Anti-tumor activity analyses showed that r-AD inhibited the growth of two mouse cell lines, hepatoma MH134 and fibrosarcoma Meth A, strongly in vitro at concentrations in excess of 10 ng ml-1. Moreover, when MH134-implanted mice were given single intravenous injections of r-AD at doses of 50 mg kg-1 and higher, their survival times were prolonged significantly. These results, taken together, indicate that the enzymatic properties and biological actions of r-AD were highly consistent with those of Mycoplasma AD.
 ...
PMID:High-level expression of Mycoplasma arginine deiminase in Escherichia coli and its efficient renaturation as an anti-tumor enzyme. 776 34


1 2 3 Next >>